Drugs.com Blog

The Official Drugs.com Blog

Introducing the Drugs.com redesign

By

After a lot of effort from our NY brand agency and in-house designers, we have started to roll out a new look for Drugs.com. First step is a logo and menu change. At the same time we have a team working through updating all the mobile apps, Facebook, Google+, Twitter and Youtube channels. Wow, we’re […]

Q4 2013 Drug Sales Data Released: Tecfidera Growth On a Rapid Transit

By

Drugs.com has released the latest U.S. drug sales data. While the ranking of the top three drugs by sales — Abilify, Nexium and Humira — remains the same, Lilly’s Cymbalta drops from fourth to seventh and forfeits close to $319 million in sales due to generic availability. Nexium’s growth tapers too, possibly due to looming […]

Drugs.com and TrialReach to Give Patients Access to Drugs In Development

By

Drugs.com, the leading online clinical drug resource, and TrialReach are partnering to provide patients with information and access to treatments that are still under development. This partnership will bring TrialReach’s patient-centric content and tools directly to the 25+ million people who visit Drugs.com every month. From a patient’s perspective, clinical trials offer more treatment options […]

Looking Back at 2013

By

The end of the year is always a good time to reflect back on healthcare innovations, major drug approvals, and frankly, things that could have possibly gone a tad bit better. From advances in hepatitis C virus treatments, to over-the-counter availability of emergency contraception, the year had lots of positive healthcare hits. But a few […]

Q3 2013 Drug Sales Data Released: Top Five Drugs Each Post Over $1 Billion in Sales

By

The latest U.S. drug sales data has been released by Drugs.com. Rankings for the top five drugs by sales remain unchanged in the third quarter. Otsuka’s antipsychotic Abilify and AstraZeneca’s Nexium retain their number one and two spots, respectively. Nexium, the top proton pump inhibitor faces sizable over-the-counter competition, a looming Rx-to-OTC switch, and patent […]

Drugs.com Recognizes American Pharmacists Month

By

Pharmacists Recognized for Their Valuable Role in Healthcare October is a special month here at Drugs.com – it’s American Pharmacists Month, spearheaded by the American Pharmacists Association (APhA). We are pharmacists ourselves, so naturally we like to take time this month to recognize the many pharmacists in the U.S. that work to improve patient care, […]

Drugs.com Pill Reminder App now free on Apple app store

By

The popular and easy-to-use Pill Reminder app for iPhone or iPod touch is now free to everyone. Use this application to manage any combination of medications, vitamins/supplements and birth control pills. The intuitive interface lets you build a list of medications and setup reminders with ease in just a few seconds using the built-in database of […]

Q2 2013 Drug Sales Data Released: Humira Climbs and Posts Double-Digit Growth

By

The latest U.S. drug sales data has been released by Drugs.com. Since Q2 2012, Otuska’s antipsychotic Abilify and AstraZeneca’s acid reducer Nexium have held either the number one or two spot in top dollar sales. This quarter, both agents continue to maintain their stronghold; each post close to $1.5 billion in sales. Humira, AbbVie’s key […]

Drugs.com Receives Fourth Webby Nomination!

By

We are extremely proud to announce that Drugs.com has been nominated for the prestigious Webby Awards. Kudos to the hard working team! This is their fourth nomination in five years. To yet again be judged among the Internet’s top 5 health web sites is indeed an honor. But wait, there’s more… we need your vote! The […]